Phosphodiesterase 4 inhibitors vs placebo
Change in FVC · patients with stable chronic obstructive pulmonary disease
1 finding from 1 review
- Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease 2020 · Cochrane Headline outcomes onlyno estimate extracted17 studies · 22108 participantsHigh